A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease

Journal of the American College of Cardiology

Volumn 44, Issue 7, 2004, Pages 1429-1435

  Hovingh, G Kees ^a   Brownlie, Alison ^b   Bisoendial, Radjesh J ^a   Dube, Marie Pierre ^b   Levels, Johannes H M ^a   Petersen, Wilma ^a   Dullaart, Robin P F ^c   Stroes, Erik S G ^a   Zwinderman, Aeilko H ^a   De Groot, Eric ^a   Hayden, Michael R ^b,d   Kuivenhoven, Jan Albert ^a   Kastelein, John J P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Xenon Genetics Inc   (Canada)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ADULT; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM LESION; EVALUATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENETIC DISORDER; HETEROZYGOTE; HUMAN; HYPO ALPHA LIPOPROTEINEMIA; HYPOLIPOPROTEINEMIA; INTIMA; LIPID METABOLISM; MALE; MULTIVARIATE ANALYSIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIBLING; THICKNESS; TUNICA MEDIA;

ADULT; APOLIPOPROTEIN A-I; ARTERIES; ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HETEROZYGOTE; HUMANS; HYPERPLASIA; LEUCINE; MALE; MIDDLE AGED; MUTATION; PROLINE; RISK ASSESSMENT; RISK FACTORS;

EID: 4644356978     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.06.070     Document Type: Article

References (41)

1. D.J. Gordon, B.M. Rifkind High-density lipoprotein - the clinical implications of recent studies N Engl J Med 321 1989 1311 1316
2. J.J. Genest Jr., S.S. Martin-Munley, J.R McNamara Familial lipoprotein disorders in patients with premature coronary artery disease Circulation 85 1992 2025 2033
3. H.B. Rubins, S.J. Robins, D Collins the Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol N Engl J Med 341 1999 410 418
4. J.A. Glomset The metabolic role of lecithin: cholesterol acyltransferase: perspectives from pathology Adv Lipid Res 11 1973 1 65
5. J.R. Nofer, B. Kehrel, M Fobker HDL and arteriosclerosis: beyond reverse cholesterol transport Atherosclerosis 161 2002 1 16
6. M. Marcil, A. Brooks-Wilson, S.M Clee Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux Lancet 354 1999 1341 1346
7. R.E. Temel, R.L. Walzem, C.L Banka Apolipoprotein A-I is necessary for the in vivo formation of high-density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake J Biol Chem 277 2002 26565 26572
8. L.O. Martinez, S. Jacquet, J.P Esteve Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis Nature 421 2003 75 79
9. K. Moriyama, J. Sasaki, Y Takada A cysteine-containing truncated apo A-I variant associated with HDL deficiency Arterioscler Thromb Vasc Biol 16 1996 1416 1423
10. M. Miller, D. Aiello, H Pritchard Apolipoprotein A-I(Zavalla) (Leu159→Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease Arterioscler Thromb Vasc Biol 18 1998 1242 1247
11. D. Recalde, W. Velez-Carrasco, F Civeira Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R) Atherosclerosis 154 2001 613 623
12. C.R. Sirtori, G. Franceschini Apolipoprotein AIMilano (the first molecular variant of human apolipoproteins) Ric Clin Lab 12 1982 83 86
13. A. Brooks-Wilson, M. Marcil, S.M Clee Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency Nat Genet 22 1999 336 345
14. P.G. Frank, Y.L. Marcel Apolipoprotein A-I: structure-function relationships J Lipid Res 41 2000 853 872
15. J.P. Reeve, B. Rannala DMLE+: bayesian linkage disequilibrium gene mapping Bioinformatics 18 2002 894 895
16. H.J. Parra, H. Mezdour, N Ghalim Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates Clin Chem 36 1990 1431 1435
17. R.J. Bisoendial, G.K. Hovingh, E de Groot Measurement of subclinical atherosclerosis: beyond risk factor assessment Curr Opin Lipidol 13 2002 595 603
18. E. de Groot, J.W. Jukema, A.D Montauban van Swijndregt B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS) J Am Coll Cardiol 31 1998 1561 1567
19. M.E. Wittekoek, E. de Groot, M.H Prins Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease Atherosclerosis 146 1999 271 279
20. E.M. Lindholm, J.K. Bielicki, L.K Curtiss Deletion of amino acids Glu146→Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid Biochemistry 37 1998 4863 4868
21. H.E. Miettinen, H. Gylling, T.A Miettinen Apolipoprotein A-IFin Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene Arterioscler Thromb Vasc Biol 17 1997 83 90
22. D.J. Rader, R.E. Gregg, M.S Meng In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis J Lipid Res 33 1992 755 763
23. U. Daum, T.P. Leren, C Langer Multiple dysfunctions of two apolipoprotein A-I variants, apoA- I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers J Lipid Res 40 1999 486 494
24. E. Bruckert, A. von Eckardstein, H Funke The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano Atherosclerosis 128 1997 121 128
25. J.R. Nofer, A. von Eckardstein, H Wiebusch Screening for naturally occurring apolipoprotein A-I variants: apo A-I (delta K107) is associated with low HDL-cholesterol levels in men but not in women Hum Genet 96 1995 177 182
26. E.M. Rubin, R.M. Krauss, E.A Spangler Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI Nature 353 1991 265 267
27. J.J. Badimon, L. Badimon, V. Fuster Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit J Clin Invest 85 1990 1234 1241
28. G. Luc, J.M. Bard, J Ferrieres Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Arterioscler Thromb Vasc Biol 22 2002 1155 1161
29. H. Yokota, Y. Hashimoto, S Okubo Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD Atherosclerosis 162 2002 399 407
30. T. Matsunaga, Y. Hiasa, H Yanagi Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene Proc Natl Acad Sci USA 88 1991 2793 2797
31. R. Miccoli, A. Bertolotto, R Navalesi Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I (L141R) Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease Circulation 94 1996 1622 1628
32. D.S. Ng, L.A. Leiter, C Vezina Apolipoprotein A-I Q [-2]X causing isolated apolipoprotein A-I deficiency in a family with alpha-lipoproteinemia J Clin Invest 93 1994 223 229
33. J.M. Ordovas, D.K. Cassidy, F Civeira Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11 J Biol Chem 264 1989 16339 16342
34. M.M. de Sousa, C. Vital, D Ostler Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis Am J Pathol 156 2000 1911 1917
35. K. Ikewaki, A. Matsunaga, H Han A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease Atherosclerosis 172 2004 39 45
36. P. Pignoli, E. Tremoli, A Poli Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging Circulation 74 1986 1399 1406
37. T. Neunteufl, S. Heher, R Katzenschlager Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain Am J Cardiol 86 2000 207 210
38. Bisoendial RJ, Hovingh GK, Levels JH, et al. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 2003;107:2944-8.
39. C.R. Sirtori, L. Calabresi, G Franceschini Cardiovascular status of carriers of the apolipoprotein A-I (Milano) mutant: the Limone sul Garda study Circulation 103 2001 1949 1954
40. G. Franceschini, L. Calabresi, G Chiesa Increased cholesterol efflux potential of sera from ApoA-I Milano carriers and transgenic mice Arterioscler Thromb Vasc Biol 19 1999 1257 1262
41. S.E. Nissen, T. Tsunoda, E.M Tuzcu Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300